Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Larson

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Acta Crystallographica. Section D, Biological Crystallography|March 1, 2005
Structure of human uridine-cytidine kinase 2 determined by SIRAS using a rotating-anode X-ray generator and a single samarium derivativeTodd C Appleby, Gary Larson, I Wayne Cheney, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2005
Parallel synthesis of pteridine derivatives as potent inhibitors for hepatitis C virus NS5B RNA-dependent RNA polymeraseYili Ding, Jean-Luc Girardet, Kenneth L Smith, et al.
Acta Oncologica (Stockholm, Sweden)|October 17, 2017
Minimal toxicity after proton beam therapy for prostate and pelvic nodal irradiation: results from the proton collaborative group REG001-09 trialMichael D Chuong, William Hartsell, Gary Larson, et al.
Clinical and Translational Radiation Oncology|April 8, 2020
Patient reported outcomes following proton pencil beam scanning vs. passive scatter/uniform scanning for localized prostate cancer: Secondary analysis of PCG 001-09Mark V Mishra, Rahul Khairnar, Søren M Bentzen, et al.
Clinical and Translational Radiation Oncology|October 26, 2019
Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09Mark V Mishra, Rahul Khairnar, Søren M Bentzen, et al.
Environmental Health Perspectives|February 28, 2024
Features of the Physical and Social Neighborhood Environment and Neighborhood-Level Alzheimer's Disease and Related Dementia in South CarolinaDana M Alhasan, Gary Larson, Matthew C Lohman, et al.
Cancer Research|August 27, 2009
RDEA119/BAY 869766: a potent, selective, allosteric inhibitor of MEK1/2 for the treatment of cancerCory Iverson, Gary Larson, Chon Lai, et al.
Practical Radiation Oncology|February 26, 2019
Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry StudiesShahed N Badiyan, Michael S Rutenberg, Bradford S Hoppe, et al.
The Journal of Clinical Endocrinology and Metabolism|February 25, 2021
Longitudinal Investigation of Pubertal Milestones and Hormones as a Function of Body Fat in GirlsMadison T Ortega, John A McGrath, Lauren Carlson, et al.
Environmental Research|May 31, 2026
Revisiting the modifiable areal unit problem in the era of exposome-wide association studies: Assessing the performance of the CDC/ATSDR Social Vulnerability Index at privacy-protecting spatial scalesJonathan V Lewis, Nathaniel MacNell, Ian D Buller, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Acta Crystallographica. Section D, Biological Crystallography|March 1, 2005
Structure of human uridine-cytidine kinase 2 determined by SIRAS using a rotating-anode X-ray generator and a single samarium derivativeTodd C Appleby, Gary Larson, I Wayne Cheney, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2005
Parallel synthesis of pteridine derivatives as potent inhibitors for hepatitis C virus NS5B RNA-dependent RNA polymeraseYili Ding, Jean-Luc Girardet, Kenneth L Smith, et al.
Acta Oncologica (Stockholm, Sweden)|October 17, 2017
Minimal toxicity after proton beam therapy for prostate and pelvic nodal irradiation: results from the proton collaborative group REG001-09 trialMichael D Chuong, William Hartsell, Gary Larson, et al.
Clinical and Translational Radiation Oncology|April 8, 2020
Patient reported outcomes following proton pencil beam scanning vs. passive scatter/uniform scanning for localized prostate cancer: Secondary analysis of PCG 001-09Mark V Mishra, Rahul Khairnar, Søren M Bentzen, et al.
Clinical and Translational Radiation Oncology|October 26, 2019
Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09Mark V Mishra, Rahul Khairnar, Søren M Bentzen, et al.
Environmental Health Perspectives|February 28, 2024
Features of the Physical and Social Neighborhood Environment and Neighborhood-Level Alzheimer's Disease and Related Dementia in South CarolinaDana M Alhasan, Gary Larson, Matthew C Lohman, et al.
Cancer Research|August 27, 2009
RDEA119/BAY 869766: a potent, selective, allosteric inhibitor of MEK1/2 for the treatment of cancerCory Iverson, Gary Larson, Chon Lai, et al.
Practical Radiation Oncology|February 26, 2019
Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry StudiesShahed N Badiyan, Michael S Rutenberg, Bradford S Hoppe, et al.
The Journal of Clinical Endocrinology and Metabolism|February 25, 2021
Longitudinal Investigation of Pubertal Milestones and Hormones as a Function of Body Fat in GirlsMadison T Ortega, John A McGrath, Lauren Carlson, et al.
Environmental Research|May 31, 2026
Revisiting the modifiable areal unit problem in the era of exposome-wide association studies: Assessing the performance of the CDC/ATSDR Social Vulnerability Index at privacy-protecting spatial scalesJonathan V Lewis, Nathaniel MacNell, Ian D Buller, et al.
Pageof 3